Objective
to assess the 3-year clinical outcomes of guided FFR or angiography primary PCI in STEMI with MV disease
Study
multicentre randomised trial
Population
STEMI patients with MV disease and PPCI
Endpoints
composite of death, MI or urgent revascularisation at 3 years
/medias/8730/25-T011_Puymirat_02.jpg)
/medias/8733/25-T011_Puymirat_01.jpg)
Conclusion
an FFR-guided MV-PCI in patients with MV disease and STEMI was not better than an angiographic guided MV-PCI at 3-year follow-up
Puymirat et al. Circulation Interv. 2024; June e013913.